TIGR posts sequence data for parasite that causes trichomoniasis

October 02, 2003

Rockville, MD - Scientists at The Institute for Genomic Research (TIGR) are beginning to unravel the mysteries of the most prevalent human parasite in North America, Trichomonas vaginalis. On October 1, TIGR released the first draft assembly of the T. vaginalis genome into the public domain.

One surprising result of the initial research is that the parasite's genome, at between 80 million and 90 million DNA base pairs, is more than five times larger that had been estimated before the sequencing project began. Although the genome is not yet completed, TIGR is releasing data at regular intervals during the sequencing process for the scientific community.

T. vaginalis is the most prevalent parasite in North America, where it is responsible for approximately 5 million cases of vaginitis each year. As a result of sequencing the genome, researchers are now starting to understand some aspects of the sexually-transmitted parasite's biology.

"Identifying the complete gene set of the parasite should help researchers find new ways to treat or prevent the disease" says Jane Carlton, TIGR's lead investigator in the T. vaginalis project, which is being funded by the National Institute of Allergy and Infectious Diseases (NIAID) under cooperative agreement U01 AI050913.

Noting that scientists were surprised by the actual size of the parasite's genome, Carlton says analysis of the data should help determine "whether the genome's size results from a large number of genes or a large number of highly repetitive sequences."

T. vaginalis is of special interest to biomedical researchers because it is emerging as an important factor in facilitating HIV transmission, for example in African-American communities of the United States. Individuals infected with T. vaginalis have a significantly increased incidence of HIV transmission made possible by an aggressive immune response and a heavy influx of target cells for HIV. This response may increase the chance of entry of HIV in HIV-negative individuals. Conversely, in HIV-positive individuals, the hemorrhages that are frequently associated with T. vaginalis infection tend to worsen shedding and subsequent transmission of the virus.

In addition to its role in HIV infection, trichomoniasis is also associated with pre-term delivery, low birth-weight, increased infant mortality and predisposition to cervical cancer. Given its prevalence and the role that T. vaginalis plays in several serious medical concerns, the ability to rapidly identify potential vaccine candidates for T. vaginalis, using genomic sequence, is a priority in the research community.

The Trichomonas genome sequence is also expected to deepen the understanding of several other human pathogens. T. vaginalis is a member of a group of organisms called the amitochondriates, which do not use oxygen for metabolism. Other members of that group include Giardia lamblia, which causes traveler's diarrhea, and Entamoeba histolytica, which causes amebiasis. Various species of Entamoeba are now being sequenced by scientists at TIGR (http://www.tigr.org/tdb/e2k1/eha1/ ).
Carlton is TIGR's lead investigator on the T. vaginalis project, which is being carried out in collaboration with Patricia Johnson of the University of California-Los Angeles' Department of Microbiology, Immunology and Molecular Genetics.

The newly released sequence data can be obtained from the TIGR website at the following link: http://www.tigr.org/tdb/e2k1/tvg

The Institute for Genomic Research (TIGR), which sequenced the first complete genome of a free-living organism in 1995, is a not-for-profit research institute based in Rockville, Maryland. TIGR conducts research involving the structural, functional, and comparative analysis of genomes and gene products in viruses, bacteria, archaea, and eukaryotes.

Media Contacts:

Jane Carlton, TIGR Associate Investigator, 301-838-5855; carlton@tigr.org

Robert Koenig, TIGR Public Affairs Manager, 301-838-5880; rkoenig@tigr.org

The Institute for Genomic Research

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.